Business Description
Next Science Ltd
ISIN : AU0000041329
Description
Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with efficacy in eradicating both biofilm-based and free-floating bacteria. Its products include Bactisure, XEPERIENCE and BLASTX. The company derives revenue from North America, New Zealand, and Australia.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.18 | |||||
Equity-to-Asset | -0.06 | |||||
Debt-to-Equity | -9.52 | |||||
Debt-to-EBITDA | -0.77 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -14.35 | |||||
Beneish M-Score | -4.11 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.1 | |||||
3-Year EBITDA Growth Rate | 14.2 | |||||
3-Year EPS without NRI Growth Rate | 8.5 | |||||
3-Year FCF Growth Rate | 14.3 | |||||
3-Year Book Growth Rate | -39.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 61.51 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 22.48 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 12.03 | |||||
9-Day RSI | 18.12 | |||||
14-Day RSI | 23.13 | |||||
3-1 Month Momentum % | -36.74 | |||||
6-1 Month Momentum % | -38.75 | |||||
12-1 Month Momentum % | -36.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.38 | |||||
Quick Ratio | 1.25 | |||||
Cash Ratio | 0.2 | |||||
Days Inventory | 67.69 | |||||
Days Sales Outstanding | 61.04 | |||||
Days Payable | 258.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -13.9 | |||||
Shareholder Yield % | -1025.26 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 82.48 | |||||
Operating Margin % | -47.88 | |||||
Net Margin % | -42.74 | |||||
EBITDA Margin % | -31.12 | |||||
FCF Margin % | -28.42 | |||||
OCF Margin % | -25.87 | |||||
ROE % | -284.27 | |||||
ROA % | -92.76 | |||||
ROIC % | -221.46 | |||||
3-Year ROIIC % | 407.46 | |||||
ROC (Joel Greenblatt) % | -385.6 | |||||
ROCE % | -139.37 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.01 | |||||
EV-to-EBIT | -0.53 | |||||
EV-to-Forward-EBIT | -2.38 | |||||
EV-to-EBITDA | -0.67 | |||||
EV-to-Forward-EBITDA | -2.48 | |||||
EV-to-Revenue | 0.21 | |||||
EV-to-Forward-Revenue | 1.11 | |||||
EV-to-FCF | -0.74 | |||||
Earnings Yield (Greenblatt) % | -188.68 | |||||
FCF Yield % | -2140.61 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NXSCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Next Science Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 22.068 | ||
| EPS (TTM) ($) | -0.032 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.38 | ||
| 3-Year Sortino Ratio | -0.5 | ||
| Volatility % | 129.28 | ||
| 14-Day RSI | 23.13 | ||
| 14-Day ATR ($) | 0.005464 | ||
| 20-Day SMA ($) | 0.04707 | ||
| 12-1 Month Momentum % | -36.71 | ||
| 52-Week Range ($) | 0.0002 - 0.1133 | ||
| Shares Outstanding (Mil) | 292.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Next Science Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Next Science Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| AUD 0.145000 Cash Dividend | 2026-02-02 | 0.10 (+0.00%) |
Show
Entries
Next Science Ltd Frequently Asked Questions
What is Next Science Ltd(NXSCF)'s stock price today?
The current price of NXSCF is $0.00. The 52 week high of NXSCF is $0.11 and 52 week low is $0.00.
When is next earnings date of Next Science Ltd(NXSCF)?
The next earnings date of Next Science Ltd(NXSCF) is .
Does Next Science Ltd(NXSCF) pay dividends? If so, how much?
Next Science Ltd(NXSCF) does not pay dividend.
Press Release
Articles on Next Science Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers